Oral Mucositis in Children with Acute Lymphoblastic Leukemia After High-Dose Methotrexate Treatment Without Delayed Elimination of Methotrexate: Relation to Pharmacokinetic Parameters of Methotrexate-Reference-Cited by-同舟云学术

Oral Mucositis in Children with Acute Lymphoblastic Leukemia After High-Dose Methotrexate Treatment Without Delayed Elimination of Methotrexate: Relation to Pharmacokinetic Parameters of Methotrexate

Published:1996-01 Issue:4 Volume:13 Page:359-367
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Rask Charlotte,Albertioni Freidoun,Schrøder Henrik,Peterson Curt

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.3109/08880019609030842

Reference21 articles.

1. High-dose methotrexate: a critical reappraisal.

2. Report on Various Clinical Studies on High Dose Methotrexate in Europe (Non-Eortc)

3. Oral complications associated with cancer therapy An M. D. Anderson Cancer Center experience

4. Oral infections and septicemia in immunocompromised patients with hematologic malignancies

5. Oral mucositis and salivary methotrexate concentration in intermediate-dose methotrexate therapy for children with acute lymphoblastic leukemia

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral manifestations in pediatric patients with leukemia;The Journal of the American Dental Association;2024-09

2. Intestinal mucositis, systemic inflammation and bloodstream infections following high‐dose methotrexate treatment in childhood acute lymphoblastic leukaemia: Comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol;International Journal of Cancer;2024-08-16

3. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis;World Journal of Surgical Oncology;2024-01-11

4. Novel Aspects of Leukemia Pharmacogenomics;Leukemia;2022-10-16

5. Life‐threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia‐Singapore 2003 and 2010 clinical trials: A risk prediction model;Asia-Pacific Journal of Clinical Oncology;2022-02-08